NCT07212894

Brief Summary

Dementia is a growing health concern in Malaysia and places a heavy burden on family members who act as caregivers. Many caregivers struggle with limited knowledge, negative attitudes, and challenges in daily caregiving practices. These issues increase caregiver stress and reduce the quality of care for people living with dementia. The DemensiaKITA mobile health application was developed to support caregivers by providing educational content, self-help tools, and practical guidance. This study will evaluate whether using the DemensiaKITA app can improve caregivers' knowledge, attitudes, and caregiving practices (KAP), as well as reduce caregiver burden. This is a non-randomized controlled trial involving dementia caregivers in Kuala Lumpur and Selangor. Participants in the intervention group will use the DemensiaKITA mobile app for a set period, while the control group will continue with usual support. Outcomes will be measured before and after the intervention using validated questionnaires. The results of this study will provide evidence on the effectiveness of a locally developed mobile health application in supporting dementia caregivers in Malaysia. If successful, this digital approach may be scaled up to improve caregiver support and dementia care in other settings.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
451

participants targeted

Target at P75+ for not_applicable

Timeline
1mo left

Started Oct 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress90%
Oct 2025May 2026

First Submitted

Initial submission to the registry

October 1, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 8, 2025

Completed
2 days until next milestone

Study Start

First participant enrolled

October 10, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2026

Expected
Last Updated

October 8, 2025

Status Verified

September 1, 2025

Enrollment Period

3 months

First QC Date

October 1, 2025

Last Update Submit

October 1, 2025

Conditions

Keywords

DementiaInformal CaregiversMobile health applicationKnowledge Attitude PracticeBurden levelMalaysia

Outcome Measures

Primary Outcomes (1)

  • Change in Dementia Caregivers' Knowledge, Attitude, and Practice (KAP) Scores

    Caregiver knowledge, attitude, and practice will be assessed using validated instruments, including the Dementia Knowledge Assessment Tool (DKAT-2) and caregiver attitude and practice scales. The primary outcome is the change in KAP scores between baseline and post-intervention, comparing the intervention (DemensiaKITA app) and control (usual care) groups. Higher scores indicate better knowledge, more positive attitudes, and improved caregiving practices.

    Baseline, 1 month and 3 months after intervention start

Secondary Outcomes (1)

  • Change in Caregiver Burden Scores

    Baseline, 1 month and 3 months after intervention start

Study Arms (2)

Arm 1 (Intervention): DemensiaKITA mHealth app

EXPERIMENTAL

Arm 1: DemensiaKITA Mobile Health App Arm Description: Participants in this arm will receive access to the DemensiaKITA mobile health application. The app delivers structured dementia-related education, strategies to improve caregiver knowledge, positive attitude reinforcement, and practical caregiving tips. It also provides self-monitoring features to support caregiver well-being. Participants will be encouraged to use the application regularly throughout the study period.

Other: DemensiaKITA mobile health application

Arm 2 (Control): Usual care

EXPERIMENTAL

Arm 2: Usual Care Arm Description: Participants in this arm will continue with their usual caregiving practices and community resources. They will not have access to the DemensiaKITA mobile health application during the study period. This group serves as the comparator to evaluate the effectiveness of the intervention.

Other: Usual Care

Interventions

A mobile health application developed to support dementia caregivers. It provides structured educational modules, attitude-shaping content, and practical caregiving tips, along with self-monitoring features to reduce caregiver stress and burden. Participants in the intervention group will use the app regularly during the study period.

Arm 1 (Intervention): DemensiaKITA mHealth app

Participants assigned to the control group will continue with usual caregiving practices and community-based resources available to dementia caregivers. They will not be given access to the DemensiaKITA mobile health application during the study period. This group provides a comparator for evaluating the added benefit of th

Arm 2 (Control): Usual care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 18 years and above
  • Primary informal caregiver of a person living with dementia (family member or household member)
  • Able to read and understand Malay
  • Owns a smartphone and is able to use mobile applications
  • Provides informed consent to participate

You may not qualify if:

  • Professional/paid caregivers (e.g., nurses, domestic helpers hired solely for caregiving)
  • Caregivers of patients with conditions other than dementia
  • Individuals with severe cognitive or psychiatric illness that limits their ability to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universiti Teknologi MARA

Sungai Buloh, Selangor, 47000, Malaysia

RECRUITING

MeSH Terms

Conditions

Dementia

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurocognitive DisordersMental Disorders

Study Officials

  • Nurulizzah Mahfar

    Universiti Teknologi MARA Sg Buloh Campus

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Nurulizzah Mahfar, Medical degree

CONTACT

Nik Nairan Abdullah, MBCHB BAO

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
This is a non-randomized, single-blinded study. Participants are blinded to their group assignment (intervention or control). Care providers and investigators are aware of the allocation, but participants are not informed which group they belong to in order to reduce bias in outcome reporting.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: This study uses a parallel assignment model with two groups. Dementia caregivers in the intervention group will receive access to the DemensiaKITA mobile health application, which provides structured educational modules, caregiving practice tips, and self-monitoring tools. Caregivers in the control group will continue with usual care and standard support resources available in the community. Outcomes will be assessed in both groups at baseline and after the intervention period to evaluate differences in knowledge, attitude, practice, and caregiver burden.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

October 1, 2025

First Posted

October 8, 2025

Study Start

October 10, 2025

Primary Completion

December 31, 2025

Study Completion (Estimated)

May 31, 2026

Last Updated

October 8, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

The study will not share individual participant data (IPD) due to ethical considerations and data protection regulations in Malaysia. The data involve informal caregivers of persons living with dementia, a population considered vulnerable. Sharing de-identified datasets may still pose a risk of re-identification, especially given the relatively small sample size and localized recruitment sites. Instead, study findings will be disseminated through peer-reviewed publications, conference presentations, and summary results reported on ClinicalTrials.gov, ensuring transparency while protecting participant confidentiality.

Locations